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Influenza vaccination is less efficacious in adults older than 65 due to a decline in 
immune response with aging. It has been suggested that moderate exercise may aid in 
increasing the efficacy of the influenza vaccination in older individuals. In this study we 
evaluated the effect of moderate exercise on interferon-~y (IFN-y) response to influenza 
vaccination in elderly adults over 65. Forty-eight sedentary elderly individuals were 
randomly distributed to either an aerobic exercise group or a control flexibility group. 
Subjects in the exercise group exercised at 65-80% heart rate reserve (HHR), 25-30 min, 3 
days a week, for 18 months and the flexibility group performed low intensity 
~flexibility/balance/resistance training during the intervention. All subjects received a 
trivalent influenza vaccine prior to the intervention and received an annual vaccination the 
following year. Blood samples were acquired at pre-immunization, 1, 4, and 12 weeks post-
immunizations and IFN-y levels were then measured in peripheral blood mononuclear cells 
(PBMC) after virus stimulation. HI antibody levels were also analyzed at pre, 1, 4, 12, and 
24 weeks post-immunization and correlated with IFN-~y. One year of exercise in elderly 
female subjects was associated with enhanced IFN-y response to A/New Caledonia/99 
(H 1 N 1) and B/Shanghai/2002 influenza antigen in PBMC cultured for. 96 hours. 
A/Moscow/99, A/Fujian/2002, and B/Shanghi/2002 also stimulated PBMC collected pre and 
1 week post-immunization to produce levels of IFN-y that correlated with HI antibody 
production post influenza vaccination. In conclusion, one year of aerobic exercise in elderly 
females may help to enhance the efficacy of the influenza vaccination through enhanced 
stimulation of IFN-y which may aid in predicting HI antibody levels to help protect against 
influenza infection. 
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CHAPTER 1: INTRODUCTION 
Each year about 20,000-40,000 Americans die and 150,000 to 200,000 are 
hospitalized because of the influenza virus or influenza related pneumonia, and over 90% of 
the deaths occur in the population over-65 years old (1). The effectiveness of the influenza 
vaccine is estimated to be 68-88°Io in young adults (2,3) but in the older than 65 population 
the vaccine efficacy ranges from 50-60% (4-6). The decrease in vaccine effectiveness in the 
elderly population may be due to reduced generation of an immune response, which results in 
lower amounts of protective antibodies that prevent the attachment of the influenza virus. (5). 
Reduced vaccine effectiveness may also be the result of a decreased amount of a specific 
antibody that is needed to protect against infection in the elderly (7). Gravenstien and 
colleagues showed that influenza infection also occurs in elderly individuals that have 
antibody titers equal to or greater than titers that are considered sufficient to fight off 
influenza in the young, indicating that antibody levels that are predictive of protection in the 
young may not apply to the elderly (8). The current research therefore indicates that the 
elderly immune system may produce antibodies that are less effective than the antibodies 
produced by a younger adult. Thus, the natural decline in immune response with aging is a 
major contributor to the lack of influenza vaccine effectiveness. 
The most established effect of aging on the immune system is the decline in T-cell 
function (9). The lack of an influenza-specific T-cell response may play a key role in the 
decline of influenza vaccine efficacy with aging. The Th-2 cytokines contribute to the 
production of antibody and immune response that may help protect against influenza virus by 
enhancing influenza specific antibody proliferation by the B-cells (88). The Th-1 cytokine, 
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IFN-y, has also been known to aid in IgG antibody class-switching that may help promote 
antiviral activity (24). Therefore, the observed decline in antibody production seen with the 
elderly population following the influenza vaccine may be due to changes in cytokine levels 
with aging. (10). Production of IFN-~ in response to the influenza infection has most 
frequently been associated with the important cell-mediated cytotoxic T lymphocyte (CTL) 
response (11). The IFN-y activated CTL response is greatly correlated with influenza viral 
clearance (81). Therefore, if the vaccine failed to stimulate a protective level of antibodies in 
the older population and influenza infection occurs, then the INF-y response to influenza 
infection would play a key role in activating the CTL response and improve viral clearance. 
Several therapies have been suggested to improve immune function in the aging 
population, such as dietary restriction hormone treatment, various vitamins, and exercise 
(12). Moderate exercise has been studied and has repeatedly shown to enhance immune 
function and improve defense against infection, (13-18) although research is limited in 
studying the response to an antigen. A number of cross-sectional studies examining the 
effects of chronic exercise on the immune system have suggested increases in NK cell 
activity (13-14) PHA-stimulated lymphocyte proliferation (15) and T-cell function and 
cytokine production (15-17) compared to an untrained group (18). For instance, in one cross- 
sectional study examining aerobically trained (> 26 mUkg/min/V02 MAx) elderly women 
compared to sedentary controls, the trained group showed greater levels of NK and T cell 
production (15). Several animal studies have also found that NK function was greater after 
exercise training compared to the resting condition (19-20) and IFN-y cytokine increased in 
aged mice when challenged by a viral antigen (21). 
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In the weakened immune systems of the elderly population the effect of chronic 
exercise may be a key factor in maintaining a protective immune response to the influenza 
vaccine. Therefore, it is important to examine the role of exercise as a method to boost the 
immune response to influenza immunization in the elderly. The cell-mediated Th-1 cytokine, 
INF-y, also plays a key role in viral clearance (22-24) and may be an important indicator of a 
protective immune response in the event that an actual influenza infection occurs. However, 
the IFN-y cytokine has also been observed to decline with aging following influenza 
vaccination (lo, 53). It is also possible that IFN-y promotes antibody class switching to 
result in IgG 1 production, and studies suggest that higher IgG 1 antibody titers are associated 
with greater protection from infection (1). Thus, the lack of IFN-y may explain the lack of 
influenza vaccine effectiveness in the elderly (4). Therefore, examination of the IFN-y 
response following influenza immunization and the determination of how exercise training 
affects influenza-specific IFN-y production may provide a better understanding of how 
exercise can improve vaccine effectiveness. In addition, if the vaccine failed to result in a 
protective antibody titer and an older adult became infected with the virus, IFN-y might be 
important in promoting effective CTL resulting in viral clearance. 
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CHAPTER 2: LITERATURE REVIEW 
Interferon-y 
Interferons (IFNs) are important immune regulatory proteins called cytokines that 
play a significant role in mediating antiviral and cell growth inhibitory responses of the 
immune system. They were first identified as proteins that act in antiviral activity and are 
grouped into two types, I and II. Type I interferons are induced by virus infection and 
consist of predominately the a (leukocyte) and R (fibroblast) interferons. Type II interferon, 
also known as immune interferon or macrophage activating factor (MAF), includes interferon 
gamma (y) and is induced by mitogenic or antigenic stimulus. Type I interferons are secreted 
by virus infected cells and type II interferons are secreted by thymus derived (T) cells and 
natural killer (NK) cells. (22-24) 
IFN-y is related to type I interferons in the sense that all the interferons may defend 
against viral infection by blocking viral replication, activating the immune response and 
enhancing T-cell recognition. However, IFN-y is not related to type I interferons at the 
genetic or protein levels (25). In addition to structural differences, IFN-y is produced mainly 
by activated NK cells (26), activated T helper (Th-1) CD4+cells (27) and specific CD8+ 
lymphocyte (28-29). The production of IFN-y is active during innate and adaptive immune 
function (23). Generally, many stimulants of Th-1 helper T-cells, NK cells, and cytotoxic T- 
cells induce IFN-y production (24). Pathogenic agents such as bacteria, protozoa, and some 
viruses stimulate IL-12 production, which act on macrophages to activate NK and T cells to 
induce IFN-y production. IFN-y production is often enhanced by IL-2 (30), TNF-a (31), and 
IFN-y itself (32) and is reduced by glucocorticoids, TGF-~3, and IL-10 (23). 
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Antiviral Role of Interferon-y 
IFN-y was first recognized by its antiviral characteristics (33). Although it is not 
considered the main action of IFN-y, the role of IFN-y in directly stimulating an antiviral 
state is sufficiently established, as well as IFN-y's role in stimulating an antiviral state 
through other immune regulating agents such as activation of macrophages, MHC antigen 
presentation, and activation of cytotoxic T-lymphocytes. There have been three IFN-y 
induced genes that produce proteins that act to directly encourage an antiviral state, namely 
double-stranded (ds) RNA activated protein kinase (PKR), 2'-5' oligoadenylate synthetase 
(2-SA synthetase), and ds RNA specific adenosine deaminase (dsRAD). (22-23) 
PKR is a protein kinase that is RNA dependent and inducible by interferon types I 
and II. The concentration of PKR is considered low in most cells and can be induced to 
produce more through stimulation by interferons. Double-stranded RNA intermediates from 
DNA or RNA viruses can activate PKR. Following autophosphorylation, PKR acts to 
catalyze the phosphorylation of a group of protein substrates that includes protein synthesis 
factor eIF-2 (eukaryotic initiation factor 2). PKR acts to phosphorylate eIF-2, which 
eventually leads to a decrease in mRNA translation and protein synthesis when stimulated by 
IFN-y or virus (37-39). 
The significance of PKR in viral inhibition was demonstrated when cells 
overexpressed PKR which resulted in inhibited replication of encephalomyocardtis virus 
(EMCV) (40) and vaccinia virus (41). In a related study, mice that were treated with IFN-y 
prior to EMCV infection had lengthened survival time compared to non-IFN-y treated mice. 
The lengthened survival time was impaired when PKR-deficient mice were stimulated with 
IFN-y (42), thus supporting the role of IFN-y in the action of PKR to inhibit viral replication. 
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. Another enzyme activated by dsRNAs and interferon-y is 2'-5'-oligoadenylate 
synthetase (2-SA synthetase or OAS). OAS activation results in the use of ATP to synthesize 
oligoadenylates in a 2-SA structure. The 2-SA oligonucleotides then activate a latent 
riboendonuclease (RNaseL), which acts to corrupt single-stranded viral and cellular RNA 
following phosphodiesterase activation. This process leads to the inhibition of protein 
synthesis and viral growth (43). IFN-y plays a role in the induction of OAS (44) and may 
also induce the OAS gene through Interferon Regulatory Factor-1 (lRF-1) (45). 
The dsRNA specific adenosine deaminase (dsRAD) causes deamination of adenosine 
during posttranscriptional RNA alteration that yield inosine, and utilizes dsRNA as a 
substrate. dsRAD has been responsible for the editing of viral RNA transcripts causing 
translation to produce a nonfunctional protein (46). Upon exposure of 1000 U/ml of IFN-y 
and 300 U/ml IFN-a there was an increase in the dsRAD transcript and it was maximally 
stimulated by IFN-y after 24 hrs of treatment. (47). 
Another mechanism that may contribute to IFN-y's antiviral effects includes its 
ability to activate macrophages to produce an isoform of nitric oxide synthase (iNOS). 
Induction of iNOS following macrophage treatment by IFN-y resulted in the restriction of the 
viral replication of vaccinia virus (VV), herpes simplex virus type-1 (HSV-1), and ectromelia 
virus (EV) (48). The presence of enzymatically active iNOS resulted in a 45-100°Io reduction 
in viral replication compared to untransfected controls. iNOS activity may also rely on the 
induction of IlZF-1 by IFN-Y (49). The mechanism of nitric oxide's inhibition of virus may 
be due to its inhibition of certain iron-containing enzymes. IFN-y induced activation of 
macrophages also aids in the control of herpes simplex virus growth independent of T and B 
cells (50). This evidence indicates that the IFN-y activation of macrophages plays an 
important part in the innate immunity to viral invasion. 
IFN-y treated cells also increase expression of the human histocompatibility complex 
class I and II (24), which may also contribute to antiviral activity in the immune response. 
MHC class II molecule expression can only be enhanced by IFN-y, but MHC class I 
molecules can be stimulated by both types of interferon (24). MHC classes I and II 
molecules act by presenting antigen peptides, which are made up of degraded viral protein 
antigens, to the cytotoxic T-lymphocytes. Viral infection increases expression of both class I 
and II MHC molecules in order to stimulate CD8+ T-cells and CD4+ T-cells respectively. 
The activation of CDB+ and CD4+ T-cells through the virus specific MHC recognition is a 
major aid in the response and recovery of viral infection (22). 
In a study by Lee et al. (51), MHC class I antigen expression maintenance was 
compromised when knockout mice lacking IFN receptors or Stat-1 factor were examined. 
This suggests that IFN signaling and Stat-1 factor play an essential role in MHC I antigen 
expression and stimulation. Stat-1 factor is known to aid in IFN-y receptor signaling. A study 
by Chang et al. (52) suggested that IFN-y induced expression of MHC transactivator factor 
(CIITA), thus supporting the role of IFN-y in class II MHC expression. Thus, enhancement 
of MHC classes I and II by IFN-y aids in viral recognition by the immune system and acts in 
stimulating the process of viral clearance. 
CD4+ T-cells are divided into Tho, Thl, Th2, and Th3 classes, the classes are 
differentiated by the type of cytokines they secrete and responses they induce. Tho cells 
differentiate into Th- l , Th-2, or Th-3 cells depending on the antigen, concentration of 
antigen, antigen presenting cells, and cytokine stimulation. IFN-y plays a major role in the 
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Th-1 cell-mediated response that is known to take part in antiviral mechanisms. In the Th-1 
cytokine response IFN-y acts by stimulating B-cells to promote class switching and produce 
complement-binding antibody, enhance local inflammatory responses by activating 
macrophages, and activate antigen presentation. All the functions of the Th-1 cytokine IFN-y 
play a major role in the immediate local response and are important in elimination of viral 
infections. (27) 
IFN-y is also responsible for activating cytotoxic T-lymphocytes (CTL or CD8+ T- 
cells) which play an essential part in viral clearance (81-83). Specifically, CTL's attack viral 
peptides expressing class I MHC protein. Class I MHC antigens are presented on virally 
infected cells expressing viral antigen in association with class I MHC protein. For example, 
intracellular or internal viral proteins, nuclear proteins, and viral glycoproteins all elicit a 
CTL response. The process of CTL-mediated attack on virus-infected cells is generated from 
the release of cytoplasmic granules containing perforins (which are proteins that form pores 
in cells) and granzymes from the CTL following contact with a viral target. Perforin then 
initiates the transport of granzymes into the cytoplasm of the target cell that causes 
destruction of the DNA and apoptotic cell death (84). Therefore, since the importance of 
CTL function appears to be important for viral clearance and IFN-y plays a role in the 
stimulation of CTL activity, the measure of IFN-y may be an indication of the protective 
CTL immune response to viral infection. 
The importance of IFN-y in stimulating an effective immune response to viral 
infection has been emphasized in a number of studies involving the influenza vaccine 
immune response in young and aged populations. 
Following vaccination with influenza A and B viruses in older individuals, IFN-y was 
significantly increased in PBMC incubated with A & B influenza virus compared to non- 
vaccinated controls. These results indicate a significant role of IFN-y in the protective 
vaccine response to influenza A and B virus (53). In an animal model, IFN-y induction 
through the addition of IL-12 in mouse spleen cells resulted in significantly more rapid viral 
clearance of heterosubtypic influenza virus from the lungs after live influenza viral challenge 
compared to non-activation with II. -12 (54). Bernstein et al. observed a correlation of IFN-y 
production with both antibody and cell-mediated responses to influenza vaccination in the 
elderly (11). Therefore, IFN-y may be a sign of both a functional cell-mediated and antibody 
response to influenza vaccination in the elderly. 
Previous research has also indicated an age-related decline in IFN-y in response to 
influenza vaccination in a majority of studies. A study by Bernstein et al (10), reported that 
a decreased cell-mediated response was seen after influenza vaccination in the elderly due to 
the small levels of IFN-y produced post-vaccination. In a similar study by Quyang et al. 
(64), an age-related decline in IFN-y was observed after PBMC were stimulated by influenza 
vaccine in vitro. The results of the Bernstein and Quyang studies conflict with the previously 
reported McElhaney (53) study that indicated a significant increase in the elderly IFN-y 
response to the influenza vaccine. The difference between the studies may be due to the 
difference in strain or type of antigen (vaccine or live virus) used to stimulate the PBMC. 
The inactivated vaccine which was used to stimulate IFN-y by Bernstein et al (10) and 
Quyang et al. (64) contained a combination of all three strains (H1N1, N2N3, and B) of 
influenza vaccine and McElhaney et al (53) examined the three strains separately using a live 
virus. The only common specific strain of virus used to stimulate the cells was the 
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A/Texas/36/91 H1N1 strain in the Bernstein study and B/Harbin/7/94 in the Quyang study. 
McElhaney et al did not see any difference in IFN-y response between elderly and young 
subjects with stimulation of the A/Texas/36/91 or B/Harbin/7/94 strains. Therefore, the 
difference in the results of the studies may be due to the difference in response of vaccine 
stimulation compared to live virus stimulation of the cells. (53, lo) 
Research also suggests that the Th-2 immune response is not sufficient to promote 
recovery from influenza virus (55). Thus, the lack of Th-2 cytokine effectiveness makes the 
Th-1 cytokine response, that includes IFN-y, essential in efficient influenza virus clearance 
and recovery. A low level of IFN-'y may also be correlated with poorer antibody titer prior to 
infection resulting in a lack of protection against influenza infection. Hence, the lack of an 
effective IFN-y response to influenza vaccination in the elderly may be part of the reason 
why vaccine efficacy is much lower in the aged population. 
The various roles and functions of IFN-y are diverse, but critical in the immune 
response to infection. Without the stimulation and release of IFN-y, the immune function 
would be greatly hindered and infection would spread more rapidly and severely. IFN-y not 
only plays a large part in directing immune signals, but also in antiviral actions. Antiviral 
actions that are stimulated by IFN-y either act directly or indirectly on the antiviral response 
and aid in restricting the corrupting effects viruses may have on the body. The presence or 
absence of IFN-y can be a strong indicator of an effective or deficient immune response to 
viral infection. 
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Aging and Viral Infection 
The lifelong process of aging has been connected to a decline in various 
physiological functions including the function of the immune system and its ability to 
prevent infection. The weakening of the immune response is called immunosenescence and 
is seen in both humans and other species with various life spans. The decline in immune 
response is seen relative to their life expectancy and not chronological time. Evidence also 
suggests that immunosenescence results in greater morbidity and mortality during infectious 
disease episodes (1). 
Most of the research regarding aging and immunity has focused on attenuation of 
the T-cell immune response, a decline in antibody response to vaccination, and suppression 
of some cytokines along with increases in other cytokines. Some cytokine studies seem to 
conflict on their report of immune response with aging, such as the report of high, low, and 
unchanged response of IFN-y with aging. The conflict in studies is most likely due to the 
health status of the subjects or technique used to measure the cytokine. 
The involution of the thymus, which is the central lymphoid organ that produces 
naive T-cells, has been linked to the decline in naive T-cells observed in the aging 
population. In a study by Fagnoni et al. (59) a large decline in naive T-cells with age was 
found, from 800 cells/ul in young adults to 177 cells/ul in the older adults. The naive CD8+ 
T-cells were lower in both groups with the older individuals almost completely depleted (13 
cells/ul) (57). Influenza-specific CD8+ T-cell response is impaired in an aged population and 
could be due to a reduction in cell population expansion (58). A reduction in naive CD4+ T-
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cells has also been reported in aged mice that tend to produce low levels of Interleukin-2 (IL- 
2). With the addition of IL-2 to the CD4+ T-cells normal function was restored (59). 
The primary response of antibodies in response to infection are less effective and 
declines more rapidly in aged subjects as well as decreased binding affinity when they are 
produced compared to young subjects (60). Antibody production in elderly with response to 
the influenza vaccine is minimal compared to the response seen in younger populations and 
as few as 25% of older adults actually develop an antibody titer that is considered protective 
(1, 61). These results support the theory of a declining immune response to vaccination with 
aging. 
Cytokine production in the aging population is considered to be one of the most 
controversial topics in immunological research (62). Some of the most affected cytokines 
with aging include; IL-2, IL-10, and IFN-y. The most consistently reported change in 
cytokine production with aging is the decline in IL-2 production with increasing age (56). 
The diminished production of IL-2 is most likely due to the decrease in the IL-2 producers 
which are the naive T-cells (57). Another possible mode of depletion of IL-2 with aging is 
the lack of responsiveness and expression of IL-2 receptors (63). 
Research seems to be contradictory with regard to IFN-'y production in the elderly. 
Studies have reported a decline in IFN-'y production following ex vivo stimulation with 
influenza vaccine or endotoxin (64). Conversely, there are also many indirect (65-66) and 
direct (67) indications of an increase in IFN-y production with age. The indirect 
measurements of increases in IFN-y were indicated by enhancement of TNF-a (66), which is 
induced by IFN-y, and neopterin (65), which is a product of activated macrophages that are 
triggered by IFN-'y. Direct increases of IFN-y in elderly individuals compared to young 
l~ 
individuals was seen in phorbol myristate acetate (PMA) and calcium ionophore A23187- 
costimulated purified T cells. (67). 
Zhang et al reported a switch from Th-1 to Th-2 cytokine production with aging, 
resulting in a decrease in IFN-y production when splenic lymphocytes were stimulated by 
influenza virus in vitro (68). The same result of decreased IFN-y production was found in 
elderly subjects' T-cells stimulated by anti-CD3 antibody plus PMA (69), in 24 month aged 
mice compared to 2 month mice followed by induction of experimental systemic lupus 
erythematosus (70), and in elderly individuals whole blood after stimulation from influenza 
A and B virus (71). Therefore, it appears that a majority of recent studies have indicated a 
trend in a decrease in IFN-y with aging although it is not specifically clear yet why there is a 
difference in the results found. The differences in research may be due to the agent used to 
stimulate IFN-y. It appears that both influenza-antigen stimulated cell studies indicated a 
decline in IFN-y with age (68, 71). 
The aging immune system tends to weaken with increasing age allowing the 
chance for viral infection to increase. The susceptibility to viral infection is supported with 
declines in the CD8+ T-cells and weakened levels of cytokines and antibodies. Altered 
levels of IFN-y may also play a role in increased viral infection in the elderly. 
The weakened immune response also correlates with the lack of immune protection 
following vaccination in the older adult population. 
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Exercise and Interferon-y 
It is well known that with exercise the immune function can be altered negatively or 
positively. The changes in immune function depend on the intensity and duration of 
exercise, the age of the subjects, and length of exercise (a single bout of exercise compared to 
chronic exercise). One of the components that can be altered in the immune response during 
exercise is cytokine activity and production in addition to changes in the number of cells that 
induce cytokine production such as T-cells and NK cells. The effects of exercise on the 
specific cytokine IFN-y is not well known. Although a considerable amount of evidence 
suggests changes in the primary cells that induce IFN-y production which consist of NK cells 
and T-cells. Changes in immune response differ with acute exercise compared to chronic 
exercise. Therefore, the response from acute exercise may have no influence on the chronic 
changes in the immune system with habitual exercise. 
Acute Exercise 
Most research examining the effect of acute exercise on IFN-y production indicate 
a decrease in cytokine production immediately following exercise with a return to normal 
level within a short period of time. It is known that with exhaustive exercise there seems to 
be a great decline in immune function and this results in a sharp decline in IFN-y following 
exercise. 
In a study by Baum et al (72), the investigators found that moderate exercise 
stimulated IFN-y production which was induced by phytohaemagglutinin (PHA) 24 hrs after 
exercise, and exhaustive exercise resulted in a decrease in pre-IFN-y (induced by 
staphylococcal enterotoxin B) whole blood supernatant levels 24 hrs after exercise. The 
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evidence of a decline in IFN-y 2 hrs following exhaustive exercise was supported by 
reductions in IFN-y-producing CD8+ and CD4+ T-cells (73). IFN-y was also reduced for 
two days in mouse spleen cells following fatiguing exercise when stimulated by herpes 
simplex virus (HSV) but returned to normal levels within seven days (74). In addition, 
moderate exercise of long duration (2.5 hrs of cycling at 65% of V02 max) has also 
displayed decreased IFN-y levels in whole blood samples stimulated by T-cell surface 
antigens immediately post-exercise and 2 hrs post-exercise (75). 
Chronic Exercise 
The number of studies on chronic exercise and immune response is minimal 
compared to the amount of studies on acute exercise, and most studies involve elderly 
subjects in an attempt to counter the immunosenescence seen with aging. The lack of studies 
may be due to the time needed for these studies and ability to separate fitness effects (e.g. 
loss of weight or lower blood pressure) from the actual exercise effects (18). Ina cross- 
sectional study by Shinkai et al. (17), the study reported enhanced IL-2, IFN-y, and IL-4 
production in PHA stimulated peripheral blood mononuclear cells (PBMC) following 24 hrs 
of incubation in cells from an elderly running group compared to the age-matched sedentary 
group. However, in a recent study of regularly exercising elderly women (76), there was no 
significant difference between the cells of trained and untrained groups in the percentage and 
number of CD4+ and CD8+ IFN-y producing T-cells. This may be due to the relatively low 
intensity of exercise which consisted of walking at 57°Io of there V02 peak. 
A study by Kohut et al (74) measured HSV-I antigen stimulated IFN-y production 
in spleen cells from aged mice that exercised at a moderate intensity over an eight-week 
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period. The exercise group had a significant increase in IFN-y and IL-2 production 
compared to the control/sedentary group with no increase in IL-10 or IgM antibody 
production. IFN-y and IL-2 are associated with the cell-mediated Th-1 response and IL-10 
and IgM antibodies are associated with the humoral Th-2 immune response. Fifteen weeks 
of treadmill running rats resulted in a significant enhancement of lymphocyte proliferative 
response to mitogen and also an increase in IL-2 production (80). Moderately exercised mice 
infected with herpes simplex virus type I also had an increase in antigen stimulated IL-2 by 
spleen cells (74). Therefore, these results suggest an enhanced Th-1 cell-mediated antigen 
specific response to moderate exercise in the elderly and a change in the Th-1/Th-2 balance. 
Natural killer (NK) cell activity has been known to be greater in exercise trained 
individuals compared to anon-trained group in a number to studies indicating a strong 
connection to exercise and innate immunity. Across-sectional study indicated that older 
adults that were highly conditioned have greater levels of NK activity and T-cell response to 
mitogen compared to the sedentary control group (15). In a group of highly trained marathon 
runners and sedentary controls the only difference in immune variables between the groups 
was the NK-cell activity, which was significantly higher in the marathon runners (14). 
Similarly, a group of female elite rowers exhibited enhanced levels of NK cell activity 
compared to the non-athlete group but no other differences were observed (77). Longitudinal 
studies have also examined the effect of exercise on immune function and found that immune 
function either does not change or is improved with habitual exercise. Mitogen stimulated T- 
cell proliferation and NK-cell activity was not affected after 12-weeks of a walking program 
in elderly women (15), but was improved in another study after 16 weeks of treadmill 
exercise (13). 
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Enhancement of antibody production has also been observed in elderly physically 
active subjects compared to sedentary controls in response to an influenza antigen. The 
active elderly subjects showed superior levels of anti-influenza IgG and IgM antibodies as 
well as influenza-specific lymphocyte proliferation when compared to the sedentary controls 
(78). Regular moderate exercise can also be a stimulator of salivary IgA antibodies after 12 
months of training (79). 
Therefore, chronic exercise tends to enhance immune function in animal models as 
well as human models. Many questions still need to be answered with respect to chronic 
exercise and immune enhancement but the current evidence supports immune improvement 
with chronic exercise. 
Statement of Problem and Hypothesis 
Influenza virus infection in the elderly population results in an increase in 
morbidity and mortality from influenza-related complications including pneumonia and other 
pulmonary or cardiac problems. The influenza related complications might be due to the 
lack of vaccine efficacy in the elderly population compared to young individuals. The lack 
of vaccine response in the elderly can be attributed to their decline in immune response with 
age (immunosenescence). The decline in immune system in the elderly has partly been 
attributed to the decline in the Th-1 cytokine IFN-y that acts in immune regulation and 
antiviral activity. Research has indicated that IFN-y is important in promoting effective cell- 
mediated responses to the influenza virus. IFN-y is known to stimulate the cytotoxic T- 
lymphocyte response. Evidence supports the critical need for an optimal CTL function for 
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influenza viral clearance to occur, and declining CTL function has been reported in the 
elderly population. Thus, in order to restore the diminished CTL used in viral clearance of 
the influenza virus, IFN-y production may be crucial. In addition, IFN-y plays an important 
role in promoting antibody production in response to influenza vaccination, particularly 
IgG 1. Greater specific IgG 1 antibody titers are correlated with better protection from 
infection. 
Consequently, in order to provide a sufficient immune response to the influenza 
vaccine and lessen the morbidity and mortality in the elderly population associated with 
influenza complications, it may be beneficial to increase or stimulate IFN-y production in 
response to influenza virus or vaccine. Some evidence in animal models suggests that 
exercise may stimulate Th-1 cytokine production in response to viral infection, which 
includes IFN-y. Therefore, the analysis of IFN-~y in response to exercise in elderly 
individuals that are vaccinated with the influenza vaccine may provide great insight on a 
possible protective mechanism against mortality and morbidity caused by the influenza virus 
in the aged. 
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CHAPTER 3: MATERIALS AND METHODS 
Subjects 
Ninety-six elderly subjects, 65 years old or older that did not participate in regular vigorous 
exercise for three years prior to the study, were recruited from the local area for this study. 
All subjects were instructed to sign an informed consent form that was pre-approved by the 
Iowa State University Human Subjects review committee. The subjects also provided a 
detailed medical history report that included medication and nutritional supplement 
consumption. Subjects were previously vaccinated with the recommended influenza vaccine 
each of five years prior to the study to control for differences in antigenic history of the 
subjects. Subjects were examined by a medical doctor to determine their health status prior 
to the study and all subjects in the cardio group were approved to engage in vigorous or 
moderate exercise. A maximal exercise test monitored by a physician using the modified 
Bruce protocol determined initial aerobic fitness. After determination of fitness level, 
subjects were randomly divided into a vigorous aerobic exercise group (cardio) or a low 
intensity flexibility/balance control (flex) group. For comparisons in this investigation, only 
the subjects enrolled in the 2003-2004 years were analyzed to avoid major discrepancies in 
antigen from the different vaccines used for a total of 40 subjects. Certain subjects were also 
excluded from data analysis because they missed certain blood draw time points (Table 1). 
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Figure 1. Study time-line 
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The study lasted eighteen months and took place over two influenza seasons. In the 
fall of 2003 subjects were vaccinated with the 2003/2004 trivalent influenza vaccine 
(Immunization #1) that contained the antigens A/New Caledonia/99 (H1N1) [A1], 
A/Moscow/99 (H3N2) [A2], and B/Hong Kong/2001. Then subjects participated in an 
cardio or flexibility group for 10 months and in the fall of 2004 subjects were immunized 
with the 2004/2005 trivalent influenza vaccine (Immunization #2) which included A/New 
Caledonia/99 (H1N1) [Al], A/Fujian/2002 (H3N2) [A2], and B/Shanghai/2002 antigens. At 
two months prior to the initial influenza season and immunization #1, initial screenings took 
place to determine if the subjects could be included in the study and to assess health and 
fitness levels of subjects (see figure 1). The initial screening consisted of two baseline blood 
samples, pre-immunization, and completion of a diet questionnaire to determine use of any 
dietary supplements and to confirm dietary consistency between groups. One to eight weeks 
prior to immunization #1 a set of fitness tests designed for older adults were used to assess 
the fitness level of the subjects. The fitness tests consisted of the chair stand test, arm curl 
test, 6 minute walk test, 8 foot up and go test, 2 minute step test, back scratch test, and chair 
sit and reach test (85). Height and weight, as well as body composition, were also 
determined. Following the initial screening process, subjects were randomly distributed to 
either a flexibility (flex) group which consisted of flexibility balance/resistance training or a 
cardio group which consisted of subjects exercising at a target heart rate for 30 minutes. Each 
group also received an influenza immunization. 
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Following immunization #1 blood samples were collected at 1, 4, 12, and 24 weeks 
post-immunization. The vaccine administered was equivalent to the influenza vaccine 
released for that particular flu season. The response between the Influenza A H 1 N 1, 
Influenza A H3N2, and Influenza B antigens were assessed within each year. Following the 
10-12 month period of participation in either the cardio or flex group, two baseline blood 
samples were collected along with the assessment of aerobic capacity and psychosocial 
measures. Subjects then received immunization #2 and blood was again collected at 1, 4, 12, 
and 24 weeks post-immunization. Each blood sample was taken from 6:00 am — 8.:00 am to 
control for the possible effects of daily changes in plasma hormones such as cortisol. Blood 
draws were performed on Monday-Thursday with a random group of subjects coming on the 
various days. IFN-y cytokine production was determined at pre-immunization and 1, 4, and 
24 weeks post-immunization. 
Exercise Intervention 
After the subjects were recruited, initial screening took place and the first 
immunization was given. The participants were then randomly assigned into either a flex 
group or a cardio group. The cardio group participated in a supervised aerobic exercise 
session 3 times a week (Monday, Wednesday, Friday) for the 18 month duration of the study. 
The aerobic exercise consisted of the subjects using exercise machines, such as treadmills, 
rowing machines, airdyne, NuStep, arm ergometer, crosstrainers, ellipticals, and stationary 
bikes or cycle ergometers. The 18 month time period of exercise allowed for the necessary 
time to elicit changes in immune function as seen in various cross-sectional and experimental 
studies. The exercise session began with awarm-up and stretching. Then the subjects used 
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the aerobic exercise equipment mentioned earlier at a specific intensity, monitored by heart 
rate. Subjects started out exercising at 45-60°0 of their heart rate reserve (HRR), which was 
determined by a graded exercise test and progressed to 60-70°Io of HRR and then worked up 
to the target range of 65-80°~o HRR. The initial exercise sessions only lasted for 5-15 
minutes depending on the fatigue or discomfort associated with the new exercises. By week 
12 subjects were adjusted to exercising at 65-80°0 of HRR for a minimum of 25 minutes and 
no longer than 30 minutes, 3-4 times a week for the twelve month duration. Subjects wore 
heart rate monitors throughout their exercise time in order to respond to instant feedback 
regarding their exercise intensity. Target heart rates were readjusted throughout the study as 
subjects became more fit, due to the increased difficulty of reaching their target heart rate. 
Following immunization # 1, exercise lasted for 12 months, then immunization #2 was 
administered and subjects exercised for 6 more months until the final blood sample which 
was collected at week 77. 
The flex subjects in the study also met three times a week for 
flexibility/balance/resistance training class that included low intensity exercise. The class 
commenced with 5-10 minutes of warm-up exercises. Then participants performed 20-30 
minutes of various stretching exercises led by a certified instructor. During the stretching 
session each of the major muscle groups were stretched. Incorporated into the stretching 
sessions were elements of yoga, tai chi, and balance work. The groups utilized flex bands, 
hand weights, ropes, and some strength machines to perform their stretch sessions throughout 
the study. 
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Preparation of Blood Mononuclear Cells 
Venous blood samples were collected in EDTA-coated vacutainer tubes in 40 ml 
sample sizes. The peripheral blood mononuclear cells (PBMC) were separated from the 
heparinized blood on a Ficoll-Paque gradient (Amersheim-Pharmacia, Piscataway, NJ) 
through centrifugation. Then the cells were washed twice and adjusted to 5 x 106 cells/ml in 
AIM-V media (Gibco Laboratories, Grand Island, New York). Then 1 ml of cells were 
added to a Falcon 24-well tissue culture plate (Becton-Dickinson Labware) and 0.1 µg/ml of 
virus antigen for each strain [A 1(H 1 N 1), A2(H3N2), and B strain] was added to stimulate the 
cells. The control well only received cells and AIM-V media. These cells were then 
incubated for 48-96 hrs at 37° C in 5% CO2 and supernatant was collected at 48 and 96hrs. 
Cells then were stored at -20° C until analysis by ELISA. 
IFN-y Assay 
PBMC influenza-specific IFN-y production was measured from the supernatants 
acquired from the cells incubated with the influenza virus using an ELISA. This was 
performed by coating a 96 well enhanced protein binding ELISA plate overnight with 
capture IFN-y mAb (BD-Pharmingen). Then the plates were blocked-with PBS-10% fetal 
bovine serum (FBS) and cell supernatant samples along with the standards that were added to 
the plates. Biotinylated anti-cytokine detection mAb was then added to the plates followed 
by avidin-peroxidase in PBS-10% FBS. Finally, the substrate TMB (BD-Pharmingen) was 
added and a Bio-Rad Benchmark microplate reader determined the absorbance at 655 nm. 
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Statistical Analysis 
Data was analyzed in SPSS as a 2 way ANOVA (treatment and sex) with a repeated 
measures (time of blood collection in relation to immunization) mixed ANOVA. 
Comparisons were made with measures at the different PBMC collection points and between 
measures for the cardio and flexibility groups. The hemagglutination inhibition (HI) was 
used to determine antibody titer. The antibody data was also correlated with the IFN-y data in 
SPSS using bivariate correlations. 
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CHAPTER 4: RESULTS 
Fitness Variables 
Fitness and health variables did not differ between the cardio and flex groups prior to 
the intervention (table 1). The four main groups (2003 48hr, 2003 96hr, 2004 48hr, and 2004 
96hr) used in analysis were each analyzed separately because of the difference in number and 
type of subjects used for each analysis (Appendix). The 2004 96hr group was also analyzed 
with respect to gender since a treatment by gender interaction was observed in that group 
(Appendix). Health and fitness data for each subject was collected prior to the 10 month 
intervention and then following the intervention. Table 1 shows the combined data of all the 
subjects used in 2003 and 2004. Fitness variables examined upper and lower body 
flexibility along with agility and upper body strength. All groups improved over the ten 
month intervention period with respect to upper body strength (R/L arm curls) (p < 0.01) and 
METS (p = < 0.05). There was a treatment by time interaction with respect to improvement 
in METS, such that the cardio group improved to a greater extent than flex { p = 0.146}. 
Following the ten months of intervention the combined data (table 1) showed a 
significant time and treatment interaction with respect to METS (p = 0.05), with a greater 
improvement in the cardio group compared to the flex group in aerobic fitness. Other 
significant main time effects or a trend towards a main effect of time were observed with 
respect to the sit and reach test, a measure of lower body and back flexibility (p = 0.014), 
right shoulder flexibility (p = 0.053), and the left and right arm curl that are considered 




Table 1.1 Subject Information 
FLEX group CARDIO group 
Age (mean+ Std.Dev.) 71.0 ± 4.3 69.9 + 5.5 
Males 7 6 
Females 14 13 
Total Subjects 21 19 
Table 1.2 Fitness Variables (results shown as Mean ± SEM). 
Variable FLEX CARDIO FLEX CARDIO 
PRE- PRE- POST- POST-
intevention intervention intervention intervention 
BMI (kg/m2) 30.1 ± 1.5 29.7 ± 1.2 29.9 ± 1.4 29.3 ± 1.2 
MaxMETS 7.0+0.5 7.5+0.5 7.7+0.5* 9.3+0.5** 
(cardio fitness) 
Chair stand 14.7 + 0.5 14.3 + 0.8 13.4 + 0.8 14.6 + 1.0 
(Leg strength) 
Left Arm curl 17.2+0.7 16.4+0.7 21.9+0.8* 21.1 + 1.0* 
(Arm strength) 
Right Arm Curl 17.6 ± 0.8 16.9 ± 0.6 21.9 ± 0.7* 20.9 ± 1.2* 
Left Shoulder Flex -6.0 + 1.0 -5.4 + 1.0 -5.0 + 1.1 -5.1 + 1.1 
Right Should Flex -4.2 + 1.2 -3.3 ± 1.0 -3.1 ± 1.1 * -3.1 + 1.1 
Up and Gob° 5.2 ± 0.2 5.6 + 0.2 5.3 + 0.2 5.2 + 0.2 
Sit and Reach 3.4 ± 0.8 3.1 ± 0.7 2.7 ± 0.7* 1.5 ± 1.0* 
*main effect of time (change occurred in both CARDIO and FLEX groups, p<0.05) 
** treatment by time interaction(improvement in CARDIO > FLEX group, p = 0.05) 
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IFN-gamma Production. 
2003 48 hr IFN-y (figure 1) 
At baseline, prior to the exercise intervention, there was no significant difference 
between the cardio group and the flex group in any of the antigens used to simulate IFN-y 
production. In the H1N1 (A/New Caledonia/99) stimulated group (fig. 1 [A]) IFN-y levels 
prior to the vaccine (Pre) were significantly lower than 1 wk (p = 0.021), 4 wk (p < 0.001), 
and 3 mo (p = 0.012) indicating a main effect of time. A significant time effect was also 
observed in the H3N2 (A/Moscow/99) (p = 0.001) and B/Hong Kong/2001 (p = 0.014) 
antigen-stimulated IFN-y production in PBMC from pre-vaccination to 4 weeks post- 
vaccination. 
2003 96 hr IFN-y (figure 2) 
IFN-y levels at 96hr did not differ between treatment groups or change over time 
except in the B/Hong Kong/2001 antigen-stimulated cells where IFN-y production 
significantly decreased (p < 0.001) at 3 months post vaccination. A treatment main effect 
was observed in the H1N1 (A/New Caledonia/99) and B (B/Hong Kong/2001) antigen 
groups, such that the flex group produced greater amounts of IFN-y compared to the cardio 
group at all time points. 
2004 48 hr IFN-y (figures 3) 
IFN-y increased significantly over time in the H1N1 (A/Caledonia/99) (p < 0.001) 
and B/Shanghi/2002 (p < 0.001) stimulated cells from pre-vaccination to 1 week post. A 
significant main effect of time was also observed such that the 4 wk post-vaccination antigen 
stimulated PBMC produced a significantly lower IFN-y response than the 1 wk post group in 
the H1N1 (A/Caledonia/99) (p = 0.004), H3N2 (A/Fujian/2002) (p = 0.047), and 
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B/Shanghi/2002 (p = 0.001) antigen groups. Also, there was no significant difference 
between flex and cardio cardio groups in amount of IFN-y produced from antigen stimulated 
cells. 
2004 96 hr IFN-y (figure 4) 
All three antigen-stimulated cells that were cultured for 96 hrs increased significantly 
from pre-vaccinated levels to all post levels (p < 0.001). There was a significant gender by 
treatment interaction (p = 0.010) in the Al (A/Caledonia/99) (H1N1) antigen cells indicating 
a greater IFN-y response in the cardio female group compared to the male cardio group. The 
96 hr cultures had significantly more IFN-y compared to the 48 hr cultures (figure 7). When 
analyzed apart from the female group, the male group (figure 5.1-5.3) showed a trend (p = 
0.084) in the H1N1 (A/Caledonia/99) flex group having higher levels of IFN-y than the 
cardio group. The female group (figure 6.1-6.3) showed a significantly greater amount of 
IFN-y produced in the cardio group compared to the flex group in the H 1 N 1 
(A/Caledonia/99) (p = 0.053) and a trend in the B/Shanghai/2002 antigen (p = 0.073) 
stimulated group. Both gender groups also showed a significant time main effect (figures 
5.1-6.3) with IFN-y increasing from pre to post-vaccination for all antigens (p = 0.001-0.05). 
30 
HI antibody correlation with IFN-gamma production. 
New Antigens and Immunogenic H3N2 
The IFN-y response to antigen measured after 48 hours of culture with antigen was 
significantly correlated with antibody titer. Although the IFN-y response assessed 1 week 
post immunization tended to be a better predictor of antibody titer at 4 weeks and 3 months 
post-immunization, there were also significant correlations between IFN-y assessed pre- 
immunization and subsequent antibody titer (Tables 2 and 3). Also, the IFN-y response to 
antigen measured after 96 hours of culture with antigen was significantly correlated with 
antibody titer. However, this was only observed when IFN-y was measured prior to 
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Figure 1. (A) In vitro H 1 N 1 stimulated IFN-y production ± S .E. by PBMC collected from 2003 DMU Cardio 
(n=19) and flexibility (n=16) groups prior to vaccination (pre), 1 week, 4 week, and 3 months post vaccination 
with influenza vaccine. Supernatants were collected 48hrs post stimulation. ~ Pre < 1 & 4 wk (p < .OS) 
(B) In vitro H3N2 stimulated IFN-y production ± S.E. by PBMC collected from 2003 DMU Cardio (n=19) and 
flexibility (n=16) groups prior to vaccination (pre), 1 week, 4 week, and 3 months post vaccination with 
influenza vaccine. Supernatants were collected 48hrs post stimulation. ~ 4 wk > Pre (p < .OS) 
(C) In vitro B stimulated IFN-y production ± S.E. by PBMC collected from 2003 DMU Cardio (n=19) and 
flexibility (n=16) groups prior to vaccination (pre), 1 week, 4 week, and 3 months post vaccination with 
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Figure 2. (A) In vitro H 1 N 1 stimulated IFN-y production ± S .E. by PBMC collected from 2003 DMU cardio 
(n=13) and flexibility (n=8) groups prior to vaccination {pre), 1 week, 4 week, and 3 months post vaccination 
with influenza vaccine. Supernatants were collected 96 hrs post stimulation. 
(B) In vitro H3N2 stimulated IFN-y production ± S.E. by PBMC collected from 2003 DMU cardio (n=13) and 
flexibility (n=8) groups prior to vaccination (pre), 1 week, 4 week, and 3 months post vaccination with 
influenza vaccine. Supernatants were collected 96 hrs post stimulation. 
(C) In vitro B stimulated IFN-y production ± S.E. by PBMC collected from 2003 DMU cardio (n=13) and 
flexibility (n=8) groups prior to vaccination (pre), 1 week, 4 week, and 3 months post vaccination with 
influenza vaccine. Supernatants were collected 96 hrs post stimulation. ~ 3 mo < Pre, 1 wk, & 4 wk 
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Figure 3. (A) In vitro H 1 N 1 stimulated IFN-y production ± S .E. by PBMC collected from 2004 DMU cardio 
(n=19) and flexibility (n=21) groups prior to vaccination (pre), 1 week, 4 week, and 3 months post vaccination 
with influenza vaccine. Supernatants were collected 48 hrs post stimulation. ~ wk 1 > Pre, wk 4, & 3 mo 
(B) In vitro H3N2 stimulated IFN-y production ± S.E. by PBMC collected from 2004 DMU cardio (n=19) and 
flexibility (n=21) groups prior to vaccination (pre), 1 week, 4 week, and 3 months post vaccination with 
influenza vaccine. Supernatants were collected 48 hrs post stimulation. wk 4 < Pre, 1 wk, & 3 mo (p<.OS) 
(C) In vitro B stimulated IFN-y production ± S.E. by PBMC collected from 2004 DMU cardio (n=19) and 
flexibility (n=21) groups prior to vaccination (pre), 1 week, 4 week, and 3 months post vaccination with 
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Figure 4. (A) In vitro H 1 N 1 stimulated IFN-y production ± S.E. by PBMC collected from 2004 DMU cardio 
(n=17) and flexibility (n=19) groups prior to vaccination (pre), 1 week, 4 week, and 3 months post vaccination 
with influenza vaccine. Supernatants were collected 96 hrs post stimulation. ~ Pre < wk 1, 4, & 12 (p < .OS) 
(B) In vitro H3N2 stimulated IFN-y production ± S.E. by PBMC collected from 2004 DMU cardio (n=17) and 
flexibility (n=19) groups prior to vaccination (pre), 1 week, 4 week, and 3 months post vaccination with 
influenza vaccine. Supernatants were collected 96 hrs post stimulation. ~ Pre < wk 1, 4, & 12 (p < .OS) 
(C) In vitro B stimulated IFN-y production ± S.E. by PBMC collected from 2004 DMU cardio (n=17) and 
flexibility (n=19) groups prior to vaccination (pre), 1 week, 4 week, and 3 months post vaccination with 
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Figure 5. (A) In vitro H 1 N 1 stimulated IFN-'y production ± S .E. by PBMC collected from 2004 DMU male 
cardio (n=6) and flexibility (n=6) groups prior to vaccination (pre), 1 week, 4 week, and 3 mo post vaccination 
with influenza vaccine. Supernatants were collected 96 hrs post stimulation. ~ Pre < wk 1, 4 & 12 (p < .OS) 
(B) In vitro H3N2 stimulated IFN-y production ± S.E. by PBMC collected from 2004 DMU male cardio (n=6) 
and flexibility (n=6) groups prior to vaccination (pre), 1 week, 4 week, and 3 months post vaccination with 
influenza vaccine. Supernatants were collected 96 hrs post stimulation. ~ Pre < wk 1, 4, & 12 (p < .OS) 
(C) In vitro B stimulated IFN-y production ± S.E. by PBMC collected from 2004 DMU male cardio (n=6) and 
flexibility (n=6) groups prior to vaccination pre, 1 week, 4 week, and 3 mo post vaccination with influenza 
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Figure 6. (A) In vitro H 1 N 1 stimulated IFN-y production ± S .E. by PBMC collected from 2004 DMU female 
cardio (n=11) and flexibility (n=13) groups prior to vaccination pre, 1 week, 4 week, and 3 mo post vaccination 
with influenza vaccine. Supernatants were collected 96 hrs post stimulation. ~`~ Cardio > Flex (p = .053) 
Pre < 1 & 4 week (p < .OS) (B) In vitro H3N2 stimulated IFN-y production ± S.E. by PBMC collected from 
2004 DMU female groups prior to vaccination (pre), 1 week, 4 week, and 3 months post vaccination with 
influenza vaccine. Supernatants were collected 96 hrs post stimulation. ~ Pre < 4 week (p < .OS} 
(C) In vitro B stimulated IFN-y production ± S.E. by PBMC collected from 2004 DMU female cardio and 
flexibility groups prior to vaccination (pre), 1 week, 4 week, and 3 mo post vaccination with influenza vaccine. 
Supernatants were collected 96 hrs post stimulation.* Cardio > Flex (p = .053) ~ Pre < 1 & 4 week (p < .OS) 
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Figure 7. IFN-y produced by cardio trained individuals and. stimulated by H 1 N 1 
antigen. Supernatants were collected at 48hrs and 96hrs. 
96 hr > 48 hr (p < .OS) (Example showing IFN-y is peaking production closer to 
96 hrs compared to 48 hrs.) 
38 
IFN-y and HI Antibody Correlations 
Table 2. Pre-immunization 2003 & 2004 H3N2 and 2004 B Antigen at 48 hr vs. HI 
antibody (Response to H3N2 or NEW ANTIGENS to vaccine.) 
Pre IFN-Y Pre HI 4 wk HI 3 mo HI 6 mo HI 
2003/2004 0.284 0.236 0.306 0.399 
A/Moscow/99 p=0.136 p=0.217 p=0.137 p=0.039 
2004/2005 0.197 0.354 0.268 
A/Fujian/2002 p = 0.175 p = 0.015 p = 0.068 
2004/05 0.3 5 0 ~ 0.249 0.247 
B/Shanghi/2002 p = 0.015 p = 0.095 p = 0.098 
Table 3. l week post immunization 2003 & 2004 H3N2 and 2004 B Antigen 48 hr vs. HI 
antibody (Response to H3N2 OR NEW ANTIGENS to vaccine.) 
1wk IFN-y Pre HI 4 wk HI 3 mo HI 6 mo HI 
H3N2 03/04 0.273 0.343 0.418 0.350 
A/Moscow/99 p = 0.153 p = 0.068 p = 0.038 p = 0.074 
H3N2 04/05 0.229 0.276 0.253 
A/Fujianl2002 p = 0.113 p = 0.061 p = 0.087 
B 2004/05 0.184 0.298* 0.287 
B/Shanghi/2002 p= 0.215 p= 0.044 p= 0.05 3 
Table 4. Pre-immunization 2003 B 96 hr & H1N12004 96 hr vs. HI antibody 
(ANTIGENS CONTAINED IN THE PREVIOUS YEAR'S VACCINE) 





p = 0.020 
0.268 
p = 0.079 
0.341* 
p = 0.036 
0.451* 
p = 0.003 
H1N104/05 .146 .168 .101 
A/New Caledonial99 p = 0.322 p = 0.269 p = 0.509 
(48 hr) 
Pearson correlations are listed first, followed by p value. 
* indicates significant correlation (p < 0.05) 
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CHAPTER 5: DISCUSSION 
In the elderly population, influenza virus infection causes greater morbidity and 
mortality (1). The lack of vaccine efficacy (4-6) and immunosenescence (5,7-9) in elderly 
individuals contribute to the influenza related complications. The decline in immune 
function in response to influenza may be due to the decreased production of IFN-y (10,53) 
that plays a key role in immune regulation and viral attack (22-24). Therefore, enhanced 
IFN-y production may help restore effective influenza viral immune defense in the elderly, 
and protect in the event that infection occurs. It has been suggested that exercise may aid in 
restoring immune function of Th-1 cytokines (21), which includes IFN-y. Thus, exercise 
may help to enhance stimulation of IFN-y production in response to influenza viral challenge 
and decrease influenza related complications in the aged population. 
The purpose of this study was to determine if aerobic exercise could enhance 
interferon-gamma in response to influenza greater than non-aerobic flexibility training of 
elderly individuals that are vaccinated with the influenza vaccine. The results of this 
investigation suggest that one year of supervised aerobic exercise training at 65-85% HHR 
may improve interferon-gamma production in response to influenza vaccination in elderly 
females at peak IFN-y production times of cultured PBMC (96hrs) (Figure 6). However, the 
female cardio group only showed a larger IFN-y response in two of the three antigens (H1N1 
and B) present in the vaccine, although the pattern was the same for H3N2 but did not meet 
statistical significance. The reason for the lack of significant difference in response to the 
(H3N2) antigen may be due to the higher levels of IFN-y produced in response to the antigen 
prior to vaccination in both the flex and cardio group, therefore a greater number of subjects 
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may have been needed to detect a difference. In addition, there was no difference between 
the cardio group and flex group with respect to IFN-y production throughout the first year of 
exercise training or after a year of exercise when PBMC were cultured for less than peak 
IFN-y production times (48hrs). As expected, the amount of IFN-y did increase from pre to 1 
and 4 weeks post vaccination when stimulated by all three antigens. 
The IFN-y response gender/treatment difference in the 2004 96 hr flex and cardio 
group may be due to the difference in change of max METS and number of subjects analyzed 
within the male and female groups. The number of males used in the 2004 96 hr analysis 
was half of the female group with 12 and 24 subjects respectively. The male group 
difference in METS from pre to post intervention in the flex group was 1.1 METS and the 
difference in the cardio group was 1.4 METS. In the female group the difference in max 
METS from pre to post intervention for the flex group was .5 METS and the difference in the 
cardio group was 1.9 METS. It is possible that both male and female groups would have 
shown enhanced IFN-y production in response to the 2004/2005 A/New Caledonis/99 
(H 1 N 1) and B/Shanghai/2002 antigens at 96hr if the male group had more subjects and a 
larger difference in training effect between the flex and cardio group. In contrast, in a similar 
study by Kohut et a1. (78) there was no difference between a sedentary, moderately active, 
and active group in IFN-'y production at 96 hours when PBMC were collected at 2 weeks 
post-immunization and stimulated with all three influenza antigens. The difference in results 
of this study's 2004 96hr female group and the Kohut study results may be due to the time of 
PBMC collected and strain of antigens used in the stimulus of IFN-y. 
The IFN-y response to 2004/2005 A/New Caledonia/99 (H1N1) and B/Shanghai/2002 
influenza antigens in the cardio group was greater in the female 2004 96 hr group but the 
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2004 48hr and 2003 groups showed no difference in the response between the cardio and flex 
groups. The difference in result of the 2003 data and 2004 data can be contributed to the lack 
of training of the subjects used in the 2003 results compared to the 2004 results. The 
subjects had been trained for an entire year in the 2004 results and this may be the reason the 
female 96 hr cardio group was able to respond with a significantly greater amount of IFN-y 
than the flex group. The exercise difference is also best detected when IFN-y has reached its 
peak (96hr) rather than at an earlier time point (48hrs). 
The differences may also have other factors contributing to the small difference in the 
flex and cardio groups. The lack of difference may be due to psychosocial factors involved 
in enhancing IFN-y production with antigen stimulation. In a similar study (86) examining 
the effects of ten months of exercise training on elderly adults, IFN-y production in response 
to antigen stimulation was greater in the cardio group compared to the flex group, but when 
psychosocial factors were included the exercise treatment was no longer related to the 
increases in IFN-y production. Therefore, the flexibility group may have improved some of 
their psychosocial measures, such as depression, while attending the flexibility sessions 
which was similar to improvements in psychosocial factors of the cardio group. The similar 
psychosocial factors may have resulted in no difference in IFN-y production following 
influenza vaccination because IFN-y may be more closely related to psychosocial factors 
than exercise. Costanzo et. al. (87) also suggests in a study examining associations among 
mood, optimism, and stress to cytokine production that mild to moderate mood disturbances 
in older adults can greatly alter IFN-y production in response to live influenza virus or 
vaccine. Ogawa et al. (76) examined the effect of exercise training on IFN-y production in 
CD4+ and CD8+cells and found no significant difference between Th-1 cytokine IFN-y and 
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Th-2 cytokine IL-4 production within CD4+ and CD8+ cells between trained and untrained 
groups. Thus, IFN-y production in response to antigen maybe greatly influenced by other 
factors in addition to exercise training. 
The finding of increased IFN-'y production in the elderly over time in response to the 
influenza vaccine is also supported by McElhaney et al. (84) that compared cytokine and 
granzyme B levels in PBMC stimulated by live influenza virus. These results of increased 
IFN-y production following vaccination support the importance of the influenza vaccination 
in the elderly in order to mount a protective response to infection. 
This study also suggests a correlation between IFN-y production and HI antibody 
production following influenza vaccination. The H3N2 antigen and antigens new to the 
vaccine which tend to produce more robust immune changes in antibody and cytokines seem 
to correlate most with the HI antibody production. For example, the B/Shanghi/2002 was a 
new antigen in the 2004/2005 vaccine and produced higher antibody titer than the influenza 
H1N1 A/New Caledonia/99 that had been in the previous year's vaccine. The IFN-y 
response to the new B/Shanghi/2002 antigen was correlated with antibody titer to a greater 
extent than the response to A/New Caledonia/99 H1N1 antigen. In both years, H3N2 elicited 
a higher antibody response than H1N1 even when H3N2 had been previously contained in 
the vaccine (H3N2 in 2003 was same as H3N2 in 2002). Therefore, antigen stimulation of 48 
hr cultured PBMC collected at pre and one week post influenza vaccination produce 
quantities of IFN-y that may help to predict HI antibody production post influenza 
vaccination (table 2 & 3). In addition, we also observed 96 hour IFN-y levels, produced in 
response to B/Hong Kong/2001, tended to correlate with HI antibody titers (table 4). 
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Based on the results of this study it appears that IFN-y may play a role in 
predicting the amount of HI antibody produced in response to the influenza vaccine in elderly 
individuals. This supports the role that IFN-y plays in regulating antibody production in 
response to viral stimulation. It is known that IFN-'y aids in regulating class switching of 
IgG2a and IgG3 (24) antibodies which act to activate complement and also help activate 
macrophages and natural killer cells via F~ receptors to fight off infection. 
In the 2003 B/Hong Kong/2001 (table 4) recall antigen with 96 hr incubation the peak 
correlation occurred at 96 hours in contrast to the new and immunogenic antigen correlation 
at 48 hours. The difference in culture time may be due to the delayed IFN-y response to a 
strain used the previous year compared to the earlier response of the strain that was not used 
in the previous year. High correlation of B antigen and HI antibody may also be due to the 
increased ability of B antigen to stimulate IFN-y in older adults as indicated in a study 
McElhaney et al. (53) that examined the vaccine response to influenza in young and older 
adults. 
One possible mechanism for the increased immune response seen with exercise could 
be due to the communication between the neuroendocrine system and immune system 
through the release of neurohormones. Exercise produces various changes to neurohormones 
depending on the intensity of the bout (89). Some of the hormones effected by exercise 
include growth hormones, glucocorticoids, endorphins, and catecholamines. Research has 
suggested that glucocorticoids and catecholamines are the main stressor hormones that affect 
the immune system (90). Therefore, the effects of these hormones on the body following 
exercise may enhance the immune response with a proper dose of hormone at the appropriate 
time. A role for catecholamines in exercise-induced immune regulation is supported in a 
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study that suggested exercise-induced changes in antiviral immunity can be suppressed with 
administration of a beta-adrenergic receptor antagonist propranolol (91). Thus, research has 
suggested that a potential mechanism responsible for the exercise-induced changes in the 
immune response could be through the release of neurohormones during or after exercise. 
This study also may have some factors that could possibly limit the findings and 
conclusions. One possible limitation of this study is the relatively low number of subjects 
used during the analysis of IFN-y production at the certain time points. This was mainly due 
to the problem of some subjects missing one blood draw during the year which excluded that 
subject's results from being included in the overall results. There was also a problem with 
insufficient amount of sample from certain subjects. Another limitation would be the lack of 
a true control group since both groups attended a "fitness" class it is difficult to determine 
whether psychosocial factors altered the immune response of IFN-y. Ideally, it would be 
good to include anon-exercise/non-social interaction group. Another possible effect on the 
results could be the variation between subjects in time from the exercise bout to the 
immunization. For example, the Monday blood draw group exercised on Friday and had two 
days of rest before the blood draw or immunization. In contrast, the Tuesday and Thursday 
blood draw groups had a little less than a day of rest before their blood draw and 
immunization. Since exercise may have long lasting effects for up to 48hrs following a single 
exercise bout, blood draw/immunization time differences among groups may have an effect 
on the amount of antibodies or IFN-~y produced. After further analysis, there was no 
correlation between the day of immunization and antibodies produced. Therefore the results 
indicated no short term effects of exercise on the immunization response. Furthermore, it is 
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difficult to compare the influenza vaccine response from year to year because the change in 
antigens included in the vaccine could also limit the conclusions. 
In order to correct some of the limitations of the current study, future research should 
include more subjects and consistent antigens in the influenza vaccine from year to year. 
Future studies could also include analysis of more Th-1 and Th-2 cytokines in response to 
exercise vaccinated elderly subjects at the time points included in this study in order to 
compare the changes in immune response with various key cytokines such as IL-2 and IL-4. 
Another study involving different levels of exercise intensity, duration of exercise per bout, 
and training length may also help to provide more insight on the optimal dose of exercise 
needed to alter immune response in elderly vaccinated individuals. Other research may also 
include a younger group to compare the difference in immune response with age and 
exercise. 
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Chapter 6: Conclusions 
In conclusion, the results of this study suggest that one year of aerobic exercise 
training improves interferon-y production response to H1N1 and B antigen in influenza 
vaccinated elderly females. However, there appears to be no difference in IFN-y production 
in response to antigen between an aerobic trained and flexibility trained elderly individuals 
with less than one year of exercise training. Also, there's no difference of IFN-'y levels in 
males with over a year of training. Therefore, this study may suggest a difference in gender 
response to IFN-y production following antigen stimulation or a gender training difference in 
the elderly. Additionally, evidence suggested that antigens new to the vaccine or highly 
responsive may stimulate PBMC collected at pre and one week post influenza vaccination to 
produce quantities of IFN-y that may help to predict HI antibody production post influenza 
vaccination. Finally, one year of aerobic training in elderly females may help limit the lack 
of immune response to influenza vaccination in the aged immune system by increasing 
production of the antiviral cytokine lFN-y in response to antigen and that may help stimulate 
production of HI antibodies to aid in protection from the influenza virus. 
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2003 48hr IFN-y 
Table 1.1 Subject Information 
FLEX group 
















Left Arm curl 
(Arm strength) 
Right Arm Curl 
Left Shoulder Flex 
Right Shoulder 
Flex 
Up and Go 




30.8 ± 2.0 
6.8 ± 0.5 
15.2 ± 0.95 
17.1 ± 1.2 
17.2 ± 1.2 
-6.5 ± 1.3 
-3.5 + 1.3 
5.2 ± 0.4 




29.5 ± 1.0 





7.2 ± 0.6~` 
13.9 ± 0.7 13.0 ± 1.2 
16.5 ± 0.9 
ls.s±o.9 
-5.2 + 1.3 
-3.7 + 1.0 
5.6 ± 0.3 




28.3 ± 0.9 
13.8 ± 1.3 
21.4±1.1~ 20.2±1.3~ 
21.8 ± 1.2~ 
-5.5 + 1.5 
-3.5 + 1.3 
5.5 ± 0.3 
2.4± 1.3* 
19.8 ± 1.4~ 
-5.5 ± 1.2 
-4.0 ± 1.3 
5.4 ± 0.3 
1.8 ± 1.2~ 
* main effect of time (change occurred in both CARDIO and FLEX groups, p<0.05) 
** treatment by time interaction(improvement in CARDIO > FLEX group, p = .054) 
57 
2003 96 hr IFN-y 
Table 3.1 Subject Information 





















Left Arm curl 
(Arm strength) 
Right Arm Curl 
Left Shoulder Flex 






34.1 ± 3.1 
7.1 ± 0.9 
13.5 ± 0.6 
17.9 ± 0.4 
18.3 ± 1.1 
-6.9 + 2.3 
-5.6 ± 2.5 
5.0 ± 0.4 
3.0 ± 1.1 
CARDIO 
PRE- . intervention 
29.4 ± 1.3 
7.4 ± 0.5 
15.3 ± 1.2 
FLEX CARDIO 
POST- POST-. intervention intervention 
33.7±2.7 28.6±1.2 
7.7 +0.9* 9.1 +0.6~~ 
13.8 + 0.2 14.6 + 1.4 
16.9+0.9 23.0+0.5'~ 19.7+1.4~ 
17.4 ±0.8 
-7.7 + 1.2 
-4.2 ± 1.3 
5.9 ± 0.2 
2.0 ± 1.0 
23.4 ±0.9~ 19.4 ± 1.6~` 
-5.6+2.5~ -7.3+ 1.3~` 
-4.5 + 2.5 -4.2 + 1.5 
4.9 ± 0.3 5.6 ± 0.2 
3.8± 1.2 -.42± 1.3~* 
* main effect of time (change occurred in both CARDIO and FLEX groups, p<0.05) 
** treatment by time interaction(improvement in CARDIO > FLEX group, p<0.077) 
a treatment by time by sex interaction (improvement in MALE FLEX group, p = 0.049) 
b main effect of sex (FEMALE > MALE group, p = .056) 





2004 48 hr IFN-y 
Table 2.1 Subject Information 
FLEX group 
















Left Arm curl 
(Arm strength) 
Right Arm Curl 
Left Shoulder Flexa
Right Should Flex 
Up and Gob°





7.3 ± 0.5 
14.5 ± 0.5 
17.8 ± 0.7 
17.6 ± 0.8 
-6.0 + 1.0 
-3.6 ± 1.2 
5.1 ± 0.2 
3.4 ± 0.8 
CARDIO FLEX CARDIO 
PRE- POST- POST-
intervention intervention intervention 
29.7 ± 1.2 29.9 ± 1.4 29.3 ± 1.2 
7.2±0.5 8.1 ±0.5~ 9.0±0.5** 
15.7±0.8 15.7±0.8 15.4± 1.0 
16.9±0.7 22.2±0.8* 20.9± 1.0~` 
16.9 ± 0.6 
-6.3 + 1.0 
-4.0 ± 1.0 
5.7 ± 0.2 
2.8 ± 0.7 
21.9±0.7~` 20.9± 1.2~ 
-5.0 + 1.1 -5.6 + 1.1 
-2.8± l.l* -3.5± 1.1* 
4.8 ±0.2~ 5.4±0.2* 
2.9±0.7~ 1.2± 1.0~ 
*main effect of time (change occurred in both CARDIO and FLEX groups, p<0.05) 
** treatment by time interaction(improvement in CARDIO > FLEX group, p = 0.146) 
a treatment by time by sex interaction (improvement in MALE FLEX group, p = 0.054) 
b main effect of treatment (FLEX < CARDIO group, p = 0.050) 
main effect of sex (FEMALE < MALE group, p = 0.031) 
59 
2004 96 hr IFN-y (Both Genders) 
Table 4.1. Subject Information 





















Left Arm curl 
(Arm strength) 
Right Arm Curl 
Left Shoulder Flex 
Right Should Flexa
Up and Go 




28.6 ± 1.2 
7.5 ± 0.4 
14.0 ± 0.6 
16.8 ± 0.9 
16.4 ± 0.9 
-4.7 ± 1.1 
-2.7 ± 1.1 
5.2 ± 0.3 




29.0 ± 1.1 
7.3 ± 0.5 




28.5 ± 1.1 28.4 ± 1.0 
8.1 ±0.5* 9.2±0.5** 
15.4 ± 1.0 14.9 ± 1.0 
16.5±0.9 21.6±0.9'~ 20.3± l.l~ 
16.8 ± 0.9 
-6.2 ± 1.1 
-4.4 ± 1.1 
5.6 ± 0.2 
2.6 ± 0.8 




2.3 ± 0.9~ 0.4 ± 1.0~ 
* main effect of time (change occurred in both CARDIO and FLEX groups, p<0.05) 
** treatment by time interaction(improvement in CARDIO > FLEX group, p=0.064) 
a treatment by sex interaction (increase in r~MALE group over time, p = 0.030) 
60 
2004 96 hr IFN-y (Male) 
Table 5.1 Subject Information 
Age (mean± Std.Dev.) 
Males 
Total Subjects 
FLEX group CARDIO group 
71.0 ± 2.1 68.5 ± 2.4 
6 6 
6 6 







Left Arm curl 
(Arm strength) 
Right Arm Curl 
Left Shoulder Flex 
Right Should Flex 
Up and Go 





7.5 ± 0.9 
15.9 ± 0.5 
18.8 ± 1.0 
18.8 ± 0.8 
-5.4 ± 1.9 
-2.2 ± 2.5 
5.5 ± 0.9 




29.3 ± 1.8 
8.1 ± 1.1 
15.1±1.7 
17.2 ± 1.6 
16.5 ± 1.1 
-5.9 ± 2.3 
-3.0 ± 1.8 
6.1 ± 0.2 





8.6± 1.1~ 9.5± 1.3~ 
18.2 + 1.9 14.9 ± 1.4 
21.0±1.0'~ 20.9±1.5~ 
20.4 ± 0.2 ~ 20.6 ± 1.9 ~ 
-5.0 ± 2.4 -5.8 ± 2.5 
-2.7 ± 2.1 -3.1 ± 2.0 
5.1 ± 0.4 6.0 ± 0.3 
1.5 ± 1.0 0.8 ± 2.8 
* main effect of time (change occurred in both CARDIO and FLEX groups, p<0.05) 
61 
2004 96 hr IFN-y (Female) 
Table 6.1 Subject Information 
FLEX group CARDIO group 
Age (mean± Std.Dev.) 70.9 + 1.2 70.2 + 1.6 
Females 13 11 
Total Subjects 13 11 
Table 6.2. Fitness Variables (results shown as Mean + SEM). 
Variable FLEX CARDIO FLEX CARDIO 
PRE PRE POST POST 
BMI (kg/m2) 29.2 + 1.7 28.8 ± 1.4 29.2 ± 1.4 28.0 + 1.3 
MaxMETS 6.9+0.5 7.0+0.4 7.4+0.5* 8.9+0.4** 
(cardio fitness) 
Chair stand 13.3 + 0.7 15.4 + 1.2 14.4 + 1.2 14.9 + 1.4 
(Leg strength) 
Left Arm curl 16.5 + 1.2 16.8 + 1.1 22.0 + 1.2* 20.1 + 1.5* 
(Arm strength) 
Right Arm Curl 15.4 ± 1.1 17.0 ± 1.2 21.1 ± 1.2* 20.2 ± 1.6* 
Left Shoulder Flex -5.6 + 1.4 -6.4 + 1.2 -4.9 + 1.6* -5.3 + 1.2* 
Right Should Flex -4.1 + 1.3 -3.8 + 1.4 -2.9 + 1.4* -3.1 ± 1.4* 
Up and Go 5.3±0.4 5.6±0.3 5.3+0.4* 5.1±0.2** 
Sit and Reach 3.8 ± 1.1 2.6 ± 0.9 3.6 ± 1. l * 1.2 ± 0.9* 
* main effect of time (p<0.05) ** tmt by time interaction (CARDIO > FLEX, p=0.004) 
